戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                            A total of 1,014 patients were included in the analyses; 96 were exposed to de
2                                          Finally, these 100 patients were included in the study.
3 ng inclusion and exclusion criteria were identified and 132 patients were included in the matched dataset (tocilizumab =
4                                  A total of 220 eyes of 147 patients were included in this analysis (US-Cat: n = 74 patie
5 herefore excluded from efficacy analyses; the remaining 151 patients were included in the per-protocol efficacy analyses.
6                                              A total of 180 patients were included in the trial (n = 80 observational and
7 in The Netherlands from August 2016 through March 2018; 189 patients were included in the intent-to-treat analysis (mean
8                                     In total, 2007 and 2040 patients were included in the surgery group and the control g
9                                    Forty-seven eyes from 24 patients were included in this study.
10                                              A total of 249 patients were included in this study.
11 cluded in the group with ITBA (n = 10 of 35; 28.6%), and 25 patients were included in the group without ITBA.
12          From February 2012 to January 2016, a total of 280 patients were included in the trial (laparoscopic surgery: n
13                                           Thirty eyes of 30 patients were included in the study.
14                                              A total of 305 patients were included in this study.
15                     Three hundred twenty-nine eyes from 329 patients were included in this study: 90 nondiabetic patients
16                                               A total of 33 patients were included in this study (12 healthy, 10 with CRS
17                                            A total of 1,394 patients were included in the study cohort (n = 700 in the pr
18                                              A total of 418 patients were included in the analysis.
19                                      A total of 595 and 422 patients were included in the pre-intervention and interventi
20                                     Forty-five eyes from 45 patients were included in this study.
21                                           A total of 14,477 patients were included in the final analysis, with 467 patien
22                                536 SB-VCE procedures in 516 patients were included in final assessment.
23         Of 4,076 references screened, 47 studies with 6,583 patients were included in final analyses.
24                                              A total of 600 patients were included in the study (average age, 61 years; r
25                                        A total of 1 511 602 patients were included in this study: 24 892 OAG patients and
26                                   A total of 102 eyes of 63 patients were included in this study.
27  died, 13 were lost to follow up; therefore, a total of 666 patients were included in the final cohort.
28                                A total of 997 eyes from 677 patients were included in the study.
29                                                          68 patients were included in the HLH group and 34 each in the DC
30      From August 2015 through November 2019, a total of 748 patients were included in the trial after randomization - 375
31                                              In total, 7555 patients were included in this analysis, 3973 (53%) male and
32                                    A total of 93 eyes of 77 patients were included in the analysis.
33                                      Five RCTs totaling 792 patients were included in our meta-analysis after application
34                                           A total of 11,966 patients were included in the current study, of whom 3513 (29
35 data were included in the primary analysis and all assigned patients were included in the safety analysis.
36 y-four subimages (10 x 10 x 1 mm) from the remaining 71 BCS patients were included in a blinded reader study, which resul
37                                   Two hundred seventy-eight patients were included in the analysis (ranibizumab 0.5 mg, n
38                                                All enrolled patients were included in the primary and safety analyses.
39                                                       Forty patients were included in the e-HRT group (mean age 62.1 +/-
40                                        Two hundred and four patients were included in the BSX group and 179 in the ATG gr
41 ere exacerbation.Measurements and Main Results: Twenty-nine patients were included in the study (median [25th-75th percen
42                                    Thirty COVID-19-positive patients were included in this retrospective study.
43            Seventy-seven thousand three hundred seventy-six patients were included in this study.
44                                            Methods: Sixteen patients were included in this multicenter study.
45                                                         Ten patients were included in the group with ITBA (n = 10 of 35;
46                                    All eligible and treated patients were included in the analysis.
47                                                      Twenty patients were included in the study.
48                                                   Fifty-two patients were included in the analyses.
49                                                   Fifty-two patients were included in the study.
50                                                  Ninety-two patients were included in the study.